News

Computers and Newspapers

Research Collaboration Between the San Francisco VA, UCSF and CalciMedica, Inc. to Present Results on CRAC Channel Inhibitors in a Stroke Model at International Conference

LA JOLLA, CA, January 24, 2018 /PRNewswire/ — Researchers from the San Francisco Veterans Affairs Medical Center and UCSF, and CalciMedica, Inc., are presenting a …

CalciMedica Receives Fast-Track Designation for CM4620, A Novel CRAC Channel Inhibitor to Treat Acute Pancreatitis

PATIENT STUDIES EXPECTED TO BEGIN IN EARLY 2018 LA JOLLA, Calif., May 24, 2017 /PRNewswire/ — Privately-held CalciMedica, Inc., announced today that it received Fast-track …

CalciMedica Initiates Phase 1 Clinical Studies for CRAC Channel Inhibitor

LA JOLLA, Calif., January 5, 2017 /PRNewswire/ — Privately-held CalciMedica, Inc., announced that it started Phase 1 safety studies in healthy volunteers of a novel …

Scroll to Top